Grünenthal is a global leader in pain management. Our purpose is to change lives for the better – and innovation is our passion. We are driven to seek effective, life-changing medicines and solutions for patients with severe diseases and high unmet medical needs.

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 155 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global Business.

... History

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach to leadership alongside a commitment to diversity and inclusivity.

... Leadership

Beyond our overarching purpose – to improve the health of people around the globe – we want to create shared value through sustainability for our company and society as a whole.

... Responsibility

In view of our vision of a world free of pain, Grünenthal strives to provide effective medication to patients worldwide. Therefore, we continuously grow and expand our market presence and product portfolio, and we collaborate with commercial partners and multiple stakeholders from the pain management field and beyond.

... Global presence & sites

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

... Requests for funding

What we have to offer – and what we seek

We’re known for our expertise in pain and adjacent fields and have worked hard to build this reputation. Strong partnerships are fundamental to our success and our track record in this area is exceptional – our partners not only continue working with us, but are keen to extend our business relationships.

We put this success down to our integral Alliance Management Department, good communication, excellent compliance standards, strong business development and access to interesting markets. Our partners value our high-quality products and state-of-the-art production and product supply. We strengthen and develop our core markets through acquisitions, asset deals, in-licensing, commercialisation and distribution deals.

Europe

We’re focused on marketed prescription products for the retail and/or hospital business. We’re also interested in medical devices in pain or indications that target our existing customer groups:

all pain indications (including drugs for sub-populations)
inflammation
musculoskeletal diseases
perioperative care including innovative medicines and medical devices

North America

We’re looking to work with other licensing partners to grow the portfolio of products that use our innovative abuse deterrent formulation technology to treat various conditions. A typical collaboration model would be the joint, US-centred development of a product-technology combination up to approval stage. We are especially interested in partnering to produce extended/immediate/mixed release technology on a commercial scale.

Latin America

We have one of the leading regional platforms that covers all key markets in Latin America. Our focus is on products in late stage clinical development that are ready to be filed or marketed:

pain
women’s health
Central Nervous System disorders
neurology

Contract Manufacturing

Grünenthal Pro - Your CMO⁺

As a full-service CMO with over 40 years of experience, we have the expertise to tailor our solutions to meet your needs – including the manufacture of controlled drugs.

... Find out more

Out-Licensing

We are actively looking for more opportunities to collaborate. From co-development and co-marketing to co-promotion and licensing, we are open to diverse kinds of partnerships. We’re especially interested in out-license assets in countries where we haven’t yet established a presence through subsidiaries such as in North America, the Middle East and Asia, especially Japan and China.

Research and Development

As a worldwide leader in pain, we’re skilled at creating cutting-edge solutions for patients with various pain diseases. We’re keen to draw on the expertise of our partners and are always looking to collaborate on exciting new development projects, especially in relation to:

Rx products and medical devices
pain
pain-related indications

Get in touch

We’re keen to hear new ideas and discover assets that are relevant to our business. If you’re interested in partnering with us, get in touch.

... Contact us